Predict your next investment


See what CB Insights has to offer

Founded Year



Acquired | Acquired

Total Raised


About PathoLase

PathoLase, Inc. is a group of professionals, in the medical & biophotonic fields, developing light-based disinfectant devices and procedures to treat diseases caused by viral, bacterial & fungal pathogens in human tissue. The company are currently developing and licensing proven procedures and associated devices for the eradication of the fungus (Trichophyton rubrum) which is the primary pathogen responsible for toe nail fungus (Onychomycosis), currently affecting 10 million individuals in the US.

PathoLase Headquarter Location

275 Airpark Boulevard Suite 500

Chico, California, 95973,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing PathoLase

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

PathoLase is included in 1 Expert Collection, including Infectious Disease.


Infectious Disease

2,330 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.